Jill Pickard is Senior Director, Rare Disease North America, Outcomes & Analytics Field Medical Team Lead for the East. In this role, Jill and her team collaborate with Medical and Commercial colleagues to shape and implement customer-centric Medical strategies that support brand operating plans and goals. She leverages her background in strategy, data, operations and technology, as well as a passion for Rare patients, to lead and elevate this new Medical Affairs team .

Jill joined Pfizer in 2006 and has led technology initiatives across the organization, including in R&D, US Commercial Sales Force, North America Oncology Field Force and Global Marketing. As part of the Global Business Intelligence (GBI) Center of Excellence, Jill championed the design and launch of ground-breaking reporting solutions leveraging data from Pfizer’s Commercial Data Warehouse. In 2018, she moved to the Internal Medicine (IM) Commercial Effectiveness team where she where she led the IM internal partner of choice strategy for Vyndaqel, Xtandi and Eucrisa. Most recently, she was Director, Commercial Excellence Rare Disease North America where she was responsible for leading insights and developing strategies to maximize the impact of the NA Rare Disease business and launch an innovative go-to-market model. She is also a passionate Pfizer Idea Sprint Lab champion and works with teams to embrace innovative problem solving.

Prior to joining Pfizer, Jill was a Management Consultant for PricewaterhouseCoopers, IBM and Providge Consulting. She worked on IT projects for BellSouth, JPMorganChase, MMC, Cigna and Pfizer. Jill has an M.A. in Statistics from Columbia University and a B.S. in System Engineering from the University of Virginia. She lives in New Jersey with her wife Claire and two sons, Eliot (12) and Liam (10). In her spare time, she enjoys yoga, hiking, baking and cheering on her sons at swim meets and baseball games.

Summits Attended: 2022 Pride

Diverse representation is a priority for us. We're proud to say that our Summit speakers are 80% queer women, 50% women of color, 25% Black & Latinx, and 15% transgender and gender nonconforming.